British drug maker AstraZeneca plc (AZN.L, AZN) said that the US Food and Drug Administration or FDA has approved a new indication for Faslodex or fulvestrant, expanding the indication to include use with abemaciclib.
from RTT - Biotech http://ift.tt/2z5nkGX
via IFTTT
No comments:
Post a Comment